Home・Aktien・Corvus Pharmaceuticals Inc

Corvus Pharmaceuticals Inc

Open

13.07 0.46

Buy Sell

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

12.63

Max

13.14

Schlüsselkennzahlen
By Trading Economics
Einkommen	-1.4M -14M
EPS	-0.15
Angestellte	37
EBITDA	312K -12M

Empfehlungen
By TipRanks
Empfehlungen	Starkes Kaufsignal
12-Monats-Prognose	+144.02% upside

Dividenden
By Acuity
Nächstes Ergebnis	6. Aug. 2026

Marktstatistiken
By TradingEconomics
Marktkapitalisierung	-266M 1.1B
Vorheriger Eröffnungskurs	12.61
Vorheriger Schlusskurs	13.07

Corvus Pharmaceuticals Inc Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Ähnliche Nachrichten

24. Juni 2026, 23:56 UTC

Correlated Moves

NXP Semiconductors NV shares are higher in after-market trading, supported by positive momentum in the semiconductor sector and a significant rise in SOXL.

24. Juni 2026, 23:56 UTC

Correlated Moves

Intuit Inc. shares declined in after-market hours, following a broader market drop. The stock remains near the lower end of its one-month range.

24. Juni 2026, 23:56 UTC

Correlated Moves

Autodesk Inc shares are lower in after-market trading, reflecting broader market declines. The stock remains near the lower end of its one-month range.

24. Juni 2026, 23:56 UTC

Correlated Moves

Cadence Design Systems Inc shares gained in after-market trading, reflecting a slight uptick since Wednesday's close amid broader positive trends in correlated assets.

24. Juni 2026, 23:56 UTC

News

Correlated Moves

Ethereum is trading lower during Wednesday's session, reflecting broader market trends as Bitcoin also declines. The cryptocurrency remains below its 20-day moving average.

24. Juni 2026, 23:56 UTC

Correlated Moves

Cardano is lower during Wednesday's session, reflecting broader market sentiment amid Bitcoin's decline. The asset remains near the lower end of its one-month range.

24. Juni 2026, 23:52 UTC

Correlated Moves

Social Media

NVIDIA shares are higher in after-market trading amid mixed social media sentiments and increased call options, reflecting bullish interest despite concerns over sector performance.

24. Juni 2026, 23:52 UTC

News

Correlated Moves

Social Media

Applied Materials shares rose in after-market trading, boosted by strong earnings from Micron Technology and positive sentiment in the semiconductor sector.

24. Juni 2026, 23:52 UTC

News

Correlated Moves

Lam Research Corp shares rise in after-market trading, driven by positive sentiment from Micron Technology's strong results and broader semiconductor sector gains.

24. Juni 2026, 23:51 UTC

Mexican Business Confidence Remains Low at 47.5, Raising Concerns Ahead of July Survey Amidst Economic Challenges

24. Juni 2026, 23:51 UTC

Adobe Inc shares are trading lower in after-market hours. No specific company news was identified to explain the movement.

24. Juni 2026, 23:51 UTC

ETF Constituents

The Vanguard FTSE Emerging Markets ETF rose during after-market hours, bolstered by gains from Taiwan Semiconductor Manufacturing Company and United Microelectronics Corporation.

24. Juni 2026, 23:51 UTC

Correlated Moves

Social Media

Apple Inc. shares are lower in after-market trading, dropping to the lower end of their one-month range amid increased options activity and a declining S&P 500 Index.

24. Juni 2026, 23:51 UTC

O'Reilly Automotive shares declined in after-market trading, reflecting unusual weakness and positioning the stock below its 20-day moving average.

24. Juni 2026, 23:51 UTC

Kraft Heinz Co shares are lower in after-market hours, continuing a weak performance trend. The stock remains near the lower end of its one-month range.

24. Juni 2026, 23:51 UTC

Baidu Inc is rising in after-market trading, reflecting broader market gains amid easing geopolitical tensions and positive Federal Reserve assessments on large banks' resilience.

24. Juni 2026, 23:51 UTC

Correlated Moves

Microchip Technology Inc is rising in after-market trading, buoyed by strong gains in the semiconductor sector and positive investor sentiment following the Fed's stress test results.

24. Juni 2026, 23:51 UTC

JD.Com Inc. shares are higher in after-market hours, reflecting positive broader market trends. No specific company news was identified to explain the movement.

24. Juni 2026, 23:51 UTC

Costco Wholesale Corp shares are lower in after-market trading. The stock remains below its 20-day moving average amid mixed market performance.

24. Juni 2026, 23:51 UTC

Macro News

Correlated Moves

Bitcoin is under pressure as miners face margin squeezes, with revenue falling below production costs. Broader market volatility also contributes to the decline.

24. Juni 2026, 23:51 UTC

Take-Two Interactive is advancing in after-market trading, reflecting broader market gains amid positive sentiment from favorable Federal Reserve stress test results.

24. Juni 2026, 23:46 UTC

NetEase Inc shares rose in after-market trading, moving from a low of 0.35% to a high of 0.60%. No specific news was identified.

24. Juni 2026, 23:41 UTC

South Korea's Exports Expected to Continue Strong Growth Ahead of July 1 Release, Following May Surge of 53.2% Year-on-Year

24. Juni 2026, 23:41 UTC

Mixed market expectations ahead of July 1 release of MBA Mortgage Rate, with recent trends showing slight declines in rates and increased mortgage applications amid inflationary pressures.

24. Juni 2026, 23:41 UTC

ETF Constituents

Vanguard FTSE Developed Markets ETF rises in after-market trading, supported by strong performances from holdings including TM, BHP, and AZN.

24. Juni 2026, 23:41 UTC

News

The iShares Core U.S. Aggregate Bond ETF is trading lower in after-market hours, following a session marked by declines and mixed global market dynamics.

24. Juni 2026, 23:41 UTC

ETF Constituents

Social Media

SPDR S&P 500 ETF Trust trades higher in after-market hours, buoyed by strong performances from Qualcomm and Micron Technology amid significant dark pool activity.

24. Juni 2026, 23:41 UTC

News

Correlated Moves

Alphabet Inc. shares are lower in after-market hours, down $1.13 to about $345.00, amid a broader decline in the Interactive Media & Services sector.

24. Juni 2026, 23:41 UTC

Correlated Moves

Alphabet Inc. shares are lower in after-market hours, impacted by a downturn in the Interactive Media & Services sub-sector and broader market declines.

24. Juni 2026, 23:41 UTC

Event

News

Trip.com Group Ltd's stock is lower in after-market trading following a first-quarter net income decline and reduced second-quarter revenue guidance.

Peer-Vergleich

Kursveränderung

Corvus Pharmaceuticals Inc Prognose

Kursziel

By TipRanks

144.02% Vorteil

12-Monats-Prognose

Durchschnitt 31.6 USD 144.02%

Hoch 40 USD

Tief 27 USD

Basierend auf 5 Wall-Street-Analysten, die in den letzten 3 Monaten 12-Monats-Kursziele für Corvus Pharmaceuticals Inc – Dist angeboten haben.

Rating-Konsens

By TipRanks

Starkes Kaufsignal

5 ratings

Buy

Halten

Sell

Basierend auf 5 Analysten, die in den letzten 3 Monaten Aktienbewertungen für Corvus Pharmaceuticals Inc – Dist abgegeben haben.

Finanzen

Vertriebs- und Verwaltungskosten

Betriebsaufwand

Gewinn vor Steuern

Verkäufe

Umsatzkosten

Bruttogewinn aus dem Verkauf

Zinsaufwand für Schulden

EBITDA

Betriebsergebnis

Über Corvus Pharmaceuticals Inc

Corvus Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of immune modulator product candidates to treat solid cancers, T cell lymphomas, autoimmune, allergic, and infectious diseases. Its lead product candidate is soquelitinib (CPI-818), a selective covalent inhibitor of interleukin 2 inducible T cell kinase (ITK), which is in a multi-center Phase 1/1b clinical trial for the treatment of peripheral T cell lymphoma, solid tumors, and atopic dermatitis. The company is also developing ciforadenant (CPI-444), an oral small molecule antagonist of the A2A receptor that is in Phase 2 clinical trial for the treatment of metastatic renal cell cancer; and mupadolimab (CPI-006), a humanized monoclonal antibody, which is in Phase 1b clinical trial for the treatment of non-small cell lung cancer and head and neck cancer. In addition, it is developing CPI-182, an antibody designed to block inflammation and myeloid suppression that is in investigational new drug application-enabling studies, as well as CPI-935, an adenosine A2B receptor antagonist to prevent fibrosis. Corvus Pharmaceuticals, Inc. has a license afreemnt with Monash University to research, develop, and commercialize certain antibodies directed to CXCR2 for the treatment of human diseases; and Vernalis (R&D) Limited to develop, manufacture, and commercialize products containing certain adenosine receptor antagonists, including ciforadenant, as well as strategic collaboration with Angel Pharmaceuticals Co. Ltd. for the development and commercialization of mupadolimab. Corvus Pharmaceuticals, Inc. was incorporated in 2014 and is based in Burlingame, California.